Official UK procurement notice
NHS National Generic Pharmaceuticals - Wave 16a
Authority: NHS England (Central government)
What is being bought3 lots · detail below
Published requirement descriptionNHS National Framework for Generics Pharmaceuticals Wave 16a
Offer reference number: CM/PHG/24/5714
Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement:
CM/PHG/24/5714/01 Oral (plus non-parenteral) products:
CESW/LSNE/NWLN: 01/02/2027 to 31/05/2030 (40 months)
CM/PHG/24/5714/02 Hospital only products:
DLN: 01/02/2027 to 31/01/2029 (24 months)
DNW: 01/02/2027 to 31/01/2029 (24 months)
CM/PHG/24/5714/03 Hospital only (housekeeping) products:
DCE/DSW: 01/02/2027 to 30/09/2027 (8 months)
DLS/DNE: 01/02/2027 to 31/05/2028 (16 months)
CPV: Pharmaceutical products
How this framework works
From the published notice- Type
- Open framework
- Call-offs
- every call-off is a further competition among the appointed suppliers
- Bids received
- 120 bids on the busiest of 3 lots · 102 suppliers appointed
- Framework period
- 3 yrs 4 mo · up to 4 yrs from 1 Feb 2027
- Buyer regions
- UKC, UKD, UKE, UKF, UKG, UKH, UKI, UKJ, UKK
Who may buy through it
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points.
Published description of the framework
Please refer to the ITO Documents for the Operation Description.
Lots and requirements (3)Procurement structure
3 lots · all with a published valueLot #1CM/PHG/24/5714/01 Oral (plus non-parenteral) productsAwardedRenewalPublished value£39,328,544
The source published no individual description for this lot.
Lot #2CM/PHG/24/5714/02 Hospital only productsAwardedRenewalPublished value£555,563,272
The source published no individual description for this lot.
Lot #3CM/PHG/24/5714/03 Hospital only (housekeeping) productsAwardedRenewalPublished value£204,419,744
The source published no individual description for this lot.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- “NHS National Generic Pharmaceuticals - Wave 16a” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use the vehicle
- Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points.
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 21 May 2025, 18:41 BST
- Last source update
- 9 Oct 2026, 09:28 BST
- Award evaluation window
- Submission end – 1 Sept 2026
- Authority reference
CM/PHG/24/5714- FTS notice number
2026/S 000-041573- Latest notice
- Contract details notice (UK7)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-051c3aFind a Tender
How it was run
Official notice- Appointment period ends
- 8 Jun 2026, 13:00 BST
- Clarification deadline
- 1 Jun 2026, 13:00 BST
- Submission channel
- Official e-sourcing portal
- Electronic submission
- Allowed
- Accepted languages
- en
The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗
Additional information may be obtained from the abovementioned address.
Tenders must be submitted to the abovementioned address.
Timeline
21 May 2025 → 1 Feb 2027 · 10 dates- Planning notice published21 May 2025, 18:41 BST
- Market engagement168 days ago1 May 2026, 23:59 BST
NHS England is advising suppliers of an upcoming tender for the NHS National Framework Agreement for the supply of Generic Pharmaceuticals, Wave 16a to commence on 1st February 2027 for varying dates of up to 40 months with the option to extend to a maximum total contract length of 48 months.
This procurement will largely consist of hospital only products in the London North and North West regions, and will also include hospital only products in the remaining regions and oral products (plus non-parenterals) in all regions.
The purpose of this notice is to inform existing and potential new suppliers of this procurement.
Useful information for suppliers can be found here: www.england.nhs.uk/medicines-2/medicine… ↗ and the current generics workplan here: www.england.nhs.uk/publication/generics… ↗ .
Specific information regarding the products included in this procurement will be provided in the ITO, which will be issued shortly.
- Next notice expected164 days ago5 May 2026, 23:59 BST
- Tender notice published163 days ago6 May 2026, 15:34 BST
- Clarification questions by137 days ago1 Jun 2026, 13:00 BST
- Admission / appointment period ends130 days ago · period end, not a bid countdown8 Jun 2026, 13:00 BST
- Assessment summaries sent46 days ago1 Sept 2026, 00:00 BST
- Award decision expected by45 days ago1 Sept 2026, 23:59 BST
- Latest notice published7 days ago9 Oct 2026, 09:28 BST
- Today16 Oct 2026
- Contract startsin 108 days1 Feb 2027
Notice history
12 events · 5 releases on Find a Tender · since 21 May 2025- Pipeline notice published21 May 2025, 18:41 BSTUK1
- Preliminary market engagement notice published24 Apr 2026, 15:58 BSTUK2
- Published value updated to £656,468,21024 Apr 2026, 15:58 BSTwas £260,000,000
- Tender notice published6 May 2026, 15:34 BSTUK4
- Published value updated to £799,311,5606 May 2026, 15:34 BSTwas £656,468,210
- Status changed to active6 May 2026, 15:34 BST
- Procurement method changed6 May 2026, 15:34 BST
- Deadline published: 8 Jun 2026, 13:00 BST6 May 2026, 15:34 BST
- Contract award notice published1 Sept 2026, 15:46 BSTUK6
- Status changed to complete1 Sept 2026, 15:46 BST
- Contract signature expected25 Sept 2026, 23:59 BSTscheduled
- Contract details notice published9 Oct 2026, 09:28 BSTUK7
Routine re-releases (5)
- 2026-04: 1 release · 24 Apr 2026
- 2025-05: 1 release · 21 May 2025
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Lot 1 · CM/PHG/24/5714/01 Oral (plus non-parenteral) products1 award | |||
| Aspire Pharma LtdSME, Brown and Burk UK LtdSME, Ennogen Healthcare International Ltd, Farmak PharmaceuticalsSME, Flynn Pharma LtdSME, Medreich PLCSME +14 more1 Feb 2027 – 31 May 2030 · up to 31 Jan 2031Extensions: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. · Options: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. | £15,529,352 | 27 Aug 2026 | Awarded |
| Lot 2 · CM/PHG/24/5714/02 Hospital only products1 award | |||
| Aspire Pharma LtdSME, Biocon Pharma UK Ltd, Chiesi Limited, Eramol (UK) Ltd, MACARTHYS LABORATORIES LTD T/A MARTINDALE PHARMA, NOVARTIS PHARMACEUTICALS UK LIMITED +95 moreLot 2 - CM/PHG/24/2714/02 Hospital Only products DLN & DNW regions1 Feb 2027 – 31 Jan 2029 · up to 31 Jan 2031Extensions: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. · Options: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. | £393,331,872 | 27 Aug 2026 | Awarded |
| Lot 3 · CM/PHG/24/5714/03 Hospital only (housekeeping) products1 award | |||
| ACCORD-UK LTD, Brown and Burk UK LtdSME, Farmak PharmaceuticalsSME, MACARTHYS LABORATORIES LTD T/A MARTINDALE PHARMA, NOVARTIS PHARMACEUTICALS UK LIMITED, Novumgen LimitedSME +37 moreLot 3 - CM/PHG/24/5714/03 Hospital Only (Housekeeping) product DCE/DSW and DLS/DNE1 Feb 2027 – 31 May 2028 · up to 31 Jan 2031Extensions: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. · Options: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. | £21,026,178 | 27 Aug 2026 | Awarded |
Contracts
Lot 1 - CM/PHG/24/5714/01 Oral (plus non-parenteral) products · Aspire Pharma LtdSME, Brown and Burk UK LtdSME, Ennogen Healthcare International Ltd, Farmak PharmaceuticalsSME, Flynn Pharma LtdSME, Medreich PLCSME +14 more
- Signed
- 11 Sept 2026
- Value
- £15,529,352
- Period
- 1 Feb 2027 – 31 May 2030 · up to 31 Jan 2031 with extensions
- Status
- active
- Extensions
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
- Options
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
Lot 2 - CM/PHG/24/2714/02 Hospital Only products DLN & DNW regions · Aspire Pharma LtdSME, Biocon Pharma UK Ltd, Chiesi Limited, Eramol (UK) Ltd, MACARTHYS LABORATORIES LTD T/A MARTINDALE PHARMA, NOVARTIS PHARMACEUTICALS UK LIMITED +95 more
- Signed
- 11 Sept 2026
- Value
- £393,331,872
- Period
- 1 Feb 2027 – 30 Sept 2029 · up to 31 Jan 2031 with extensions
- Status
- active
- Extensions
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
- Options
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
Lot 3 - CM/PHG/24/5714/03 Hospital Only (Housekeeping) product DCE/DSW and DLS/DNE · ACCORD-UK LTD, Brown and Burk UK LtdSME, Farmak PharmaceuticalsSME, MACARTHYS LABORATORIES LTD T/A MARTINDALE PHARMA, NOVARTIS PHARMACEUTICALS UK LIMITED, Novumgen LimitedSME +37 more
- Signed
- 11 Sept 2026
- Value
- £21,026,178
- Period
- 1 Feb 2027 – 31 May 2028 · up to 31 Jan 2031 with extensions
- Status
- active
- Extensions
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
- Options
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · CM/PHG/24/5714/01 Oral (plus non-parenteral) products | 47final-stage tenders · 49 at stage one | 31 | 0 | — |
| 2 · CM/PHG/24/5714/02 Hospital only products | 120final-stage tenders · 122 at stage one | 81 | 0 | — |
| 3 · CM/PHG/24/5714/03 Hospital only (housekeeping) products | 66final-stage tenders | 43 | 0 | — |
Who bid (first 60 of 125)
- wonCHIESI LIMITED · North West England · 2
- did not winGALVANY PHARMA LIMITEDSME · East of England · 2, 3
- did not winGENNISIUM PHARMASME · 2
- did not winGILEAD SCIENCES LTD · Greater London · 2
- did not winGLAXOSMITHKLINE UK LIMITED · Greater London · 2, 1
- did not winHAMELN PHARMA LTDSME · South West England · 2, 3
- did not winGLENMARK PHARMACEUTICALS EUROPE LIMITED · Greater London · 2, 3
- did not winGRINDEKS KALCEKS UK LIMITEDSME · East of England · 2, 3
- did not winHIKMA PHARMACEUTICALS INTERNATIONAL LIMITEDSME · Greater London · 2, 3
- did not winKENT PHARMA UK LIMITED · South East England · all lots
- did not winLipomed GmbHSME · 2
- did not winLUNDBECK LIMITEDSME · East of England · 2, 3
- did not winMACLEODS PHARMA UK LIMITEDSME · North East England · all lots
- did not winMACURE PHARMA UK LIMITEDSME · Greater London · 2
- wonMACARTHYS LABORATORIES LIMITED · Greater London · all lots
- did not winMEDAC PHARMA LLP · Greater London · 2
- did not winMERCURY PHARMACEUTICALS LIMITED · Greater London · all lots
- did not winMILPHARM LIMITED · Greater London · all lots
- did not winMORNINGSIDE PHARMACEUTICALS LIMITEDSME · East Midlands · all lots
- did not winMSN LABORATORIES EUROPE LIMITEDSME · East of England · all lots
- wonNECESSITY SUPPLIES LIMITEDSME · Greater London · all lots
- did not winNEON HEALTHCARE LTDSME · East of England · all lots
- did not winNEURAXPHARM UK LIMITEDSME · Wales (Cymru) · 2, 3
- did not winNORTHUMBRIA PHARMA THROMBOSIS LIMITEDSME · North East England · 2
- wonNOVARTIS PHARMACEUTICALS UK LIMITED · Greater London · 2, 3
- wonNOVUMGEN LIMITEDSME · Greater London · all lots
- did not winOrifarm UK LtdSME · East of England · 2, 1
- did not winOTSUKA PHARMACEUTICALS (U.K.) LTD.SME · South East England · 2
- did not winPANPHARMA UK LIMITEDSME · North West England · 2
- did not winPARI MEDICAL LIMITEDSME · Greater London · 2
- did not winPERENNIAL PHARMA LTDSME · East of England · all lots
- did not winPFIZER LIMITED · South East England · all lots
- did not winPhoenix labs U.C.SME · 2
- wonPIERRE FABRE LIMITED · Greater London · 2
- did not winPIRAMAL CRITICAL CARE LIMITEDSME · Greater London · 2
- did not winPROVEPHARM UK LTDSME · Greater London · 2, 3
- did not winREIG JOFRE UK LIMITEDSME · South West England · 2, 3
- wonRIDGE PHARMA LIMITEDSME · South East England · 2, 3
- did not winROCHE PRODUCTS LIMITED · East of England · 2
- did not winROVI BIOTECH LIMITEDSME · Greater London · 2
- did not winRPH PHARMA LTDSME · North West England · all lots
- did not winSANDOZ LIMITED · South East England · all lots
- did not winSEACROSS PHARMACEUTICALS LTDSME · East of England · 2, 3
- did not winSELECTIVE SUPPLIES LIMITEDSME · Greater London · 2, 1
- did not winSERB LTDSME · South East England · 2, 3
- did not winSTRIDES PHARMA UK LTDSME · East of England · all lots
- did not winSUN PHARMA UK LIMITEDSME · Greater London · all lots
- did not winSVP PHARMA LTDSME · East of England · 2, 3
- did not winSYNCHRONY PHARMASME · Greater London · 2
- did not winTAKEDA UK LIMITEDSME · Greater London · 2
- did not winTEVA UK LIMITED · Yorkshire and the Humber · all lots
- did not winTHEA PHARMACEUTICALS LIMITED · West Midlands · 2
- did not winTHORNTON & ROSS LIMITED · Yorkshire and the Humber · all lots
- wonTillomed Laboratories LtdSME · East of England · 2, 3
- did not winTORBAY PHARMACEUTICALS LIMITEDSME · South West England · 2, 3
- did not winTORRENT PHARMA (UK) LTDSME · South East England · all lots
- did not winUNICORN PHARMACEUTICALS LIMITEDSME · Greater London · 2, 3
- did not winUSV UK LIMITEDSME · Greater London · 2, 3
- did not winVANTAGE PHARMACEUTICALS LTDSME · East of England · 2
- did not winWAYMADE PLCSME · East of England · 2
Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.
Contracting authority & participating public bodies
Framework contractors & participating bidders
125 commercial parties on the notice · 40 awardedThe first 50 of 125 commercial parties (by name); the JSON mirror lists them all.
- AFT Pharma UK LimitedFramework contractor
- AGB Pharma (UK) LtdFramework contractor
- ALISSA HEALTHCARE RESEARCH LIMITEDBidder / tenderer
- AOP Orphan LimitedFramework contractor
- ASCEND LABORATORIES (UK) LIMITEDFramework contractor
- ASCOT LABORATORIES LIMITEDFramework contractor
- ASPEN PHARMACARE UK LIMITEDFramework contractor
- ASPIRE PHARMA LIMITEDFramework contractor
- AXUNIO LTDBidder / tenderer
- Accord UK LtdFramework contractor
Show 40 more suppliers
- Aguettant LimitedFramework contractor
- Amarox LimitedFramework contractor
- Arcadia Pharma LimitedFramework contractor
- B. BRAUN MEDICAL LIMITEDFramework contractor
- BAXTER HEALTHCARE LIMITEDFramework contractor
- BEAUMONT PHARMA LTDBidder / tenderer
- BIOGEN IDEC LIMITEDBidder / tenderer
- BIOVANTIC PHARMA LIMITEDBidder / tenderer
- BOWMED IBISQUS LIMITEDFramework contractor
- BRANCASTER PHARMA LIMITEDFramework contractor
- BROWN & BURK UK LIMITEDFramework contractor
- Biocon Pharma UK LimitedFramework contractor
- C. S. T. PHARMA LIMITEDFramework contractor
- CELIX PHARMA LTDFramework contractor
- CHIESI LIMITEDFramework contractor
- CIPLA (EU) LIMITEDFramework contractor
- CLINIGEN HEALTHCARE LIMITEDFramework contractor
- COLONIS PHARMA LIMITEDFramework contractor
- CONSILIENT HEALTH (UK) LIMITEDFramework contractor
- CRESCENT PHARMA LIMITEDFramework contractor
- DAY LEWIS MEDICAL LIMITEDFramework contractor
- DESITIN PHARMA LIMITEDFramework contractor
- DR REDDY'S LABORATORIES (UK) LIMITEDFramework contractor
- DRUGSRUS LIMITEDFramework contractor
- ELI LILLY AND COMPANY LIMITEDBidder / tenderer
- ENNOGEN HEALTHCARE INTERNATIONAL LIMITEDFramework contractor
- ERAMOL (UK) LimitedFramework contractor
- ESSENTIAL PHARMA LIMITEDBidder / tenderer
- ESTEVE PHARMACEUTICALS LTDFramework contractor
- EVER PHARMA UK LIMITEDBidder / tenderer
- Evolan Pharma ABBidder / tenderer
- FARMAK PHARMACEUTICALS UK LTDFramework contractor
- FERRING PHARMACEUTICALS LTDFramework contractor
- FLEXIPHARM AUSTRADING LIMITEDFramework contractor
- FLYNN PHARMA LIMITEDFramework contractor
- FONTUS HEALTH LTDFramework contractor
- FRESENIUS KABI LIMITEDFramework contractor
- G.L. PHARMA UK LIMITEDBidder / tenderer
- GALVANY PHARMA LIMITEDFramework contractor
- GENNISIUM PHARMAFramework contractor
Official documents & specifications (16)
Official links; attachments are not copiedTender pack and attachments
Notices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract details notice Contract details notice on Find a Tender
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Pipeline notice Pipeline notice on Find a Tender